StarrMRWengCYVajzovicLBlinderKJKimJEJumperJM.Approach to ophthalmic surgery involving the anterior vitreous: a clinical practice update from the American Society of Retina Specialists. J Vitreoretin Dis. 2025;9(6):744-750.
2.
BouazizMZhuDZhuEAbizadehEJiaoGKadenTR.Outcomes of Nd:YAG laser posterior membranotomy in the treatment of macular preretinal hemorrhage: a systematic review and meta-analysis. J Vitreoretin Dis. 2025;9(6):751-759.
3.
XieYLinRZJiX, et al. Risk factors for macular hole development after pars plana vitrectomy for rhegmatogenous retinal detachment. J Vitreoretin Dis. 2025;9(6):760-765.
4.
YanWPaulRAllenPDawkinsR.Cost-utility analysis of early vitrectomy vs intravitreal biopsy and injection for endophthalmitis. J Vitreoretin Dis. 2025;9(6):766-769.
5.
BelloNRWangRCBossJ, et al. Intraocular pressure outcomes following suprachoroidal triamcinolone acetonide in patients with glaucoma, ocular hypertension, or steroid response. J Vitreoretin Dis. 2025;9(6):770-776.
6.
SattahNZhaoWChoiA, et al. Effect of faricimab on visual acuity and retinal structure in neovascular age-related macular degeneration previously treated with anti-VEGF therapy. J Vitreoretin Dis. 2025;9(6):777-783.
7.
Abou-SamraABaraziMDAbbasA, et al. Real-world experience of geographic atrophy treatment with avacincaptad pegol. J Vitreoretin Dis. 2025;9(6):784-787.
8.
OchoaAIIIBrinsonJChin LoyKYousufSJ.Associations between electronic cigarettes, smokeless tobacco, and age-related macular degeneration in the 2017 United States National Health Interview Survey. J Vitreoretin Dis. 2025;9(6):788-791.
9.
SalabatiMGarriganHMomenaeiB, et al. Clinical characteristics and long-term outcomes of eyes with neovascular age-related macular degeneration requiring frequent treatment. J Vitreoretin Dis. 2025;9(6):792-799.
10.
CottonCHoyekSMcTavishS, et al. Temporal B-scan ultrasonography findings and their relation to visual outcomes in endophthalmitis. J Vitreoretin Dis. 2025;9(6):800-810.
11.
KarthikNPatelSDJustinGA, et al. Retinal layer thickness and volume measurements in traumatic brain injury. J Vitreoretin Dis. 2025;9(6):811-819.
12.
LakeSWilliamsKBottemaMReynoldsK.Effect of vitrectomy for full thickness macular hole on three-dimensional macular shape. J Vitreoretin Dis. 2025;9(6):820-824.
13.
JesterDAChauhanMZShakarchiAFSallamAB.Publication outcomes of abstracts presented at meetings of the American Society of Retina Specialists. J Vitreoretin Dis. 2025;9(6):825-830.
14.
DuJSabbaghODoBK, et al. Low-dose 0.01% atropine eye drops for symptomatic vitreous floaters: a noninvasive, safe, and effective therapeutic option. J Vitreoretin Dis. 2025;9(6):831-835.
15.
MoorjaniRLohGKTennantMTKertesPJGrewalPS.Carbon footprint of pars plana vitrectomy, pneumatic retinopexy, and scleral buckle procedures for rhegmatogenous retinal detachment repair. J Vitreoretin Dis. 2025;9(6):836-841.
16.
ShahSMarkatiaZda CruzNFS, et al. Demographics and productivity trends among academically affiliated female retina specialists in the United States. J Vitreoretin Dis. 2025;9(6):842-848.
17.
MomenaeiBShahlaeeANguyenMK, et al. Epiretinal membrane progression following cataract surgery. J Vitreoretin Dis. 2025;9(6):849-855.
18.
KiryakozaLCSengilloJDda CruzNFS, et al. Indications and outcomes of select vitreoretinal surgery in patients with Marfan syndrome. J Vitreoretin Dis. 2025;9(6):856-861.
19.
HerreraMYiuGMoshiriAEmami-NaeiniPParkSMoussaK.Retinal detachment in incarcerated patients. J Vitreoretin Dis. 2025;9(6):862-865.
20.
AntoniettiMSchwartzSGAgueroLFlynnHWJr.Ultrasound biomicroscopy of patients with hemorrhagic complications following intravitreal anti–vascular endothelial growth factor injection. J Vitreoretin Dis. 2025;9(6):866-870.
21.
DwomohEAPrasadANandaT.Sterile intraocular inflammation in patients receiving both faricimab and high-dose aflibercept in consecutive order. J Vitreoretin Dis. 2025;9(6):871-875.
Burggraaf-Sánchez de las MatasRGarijo-BufortMJuan-RibellesBBenavent-CoraiVOrtiz-SalvadorMGimeno-BroselMT.Panuveitis associated with idiopathic hypereosinophilic syndrome. J Vitreoretin Dis. 2025;9(6):881-886.
24.
BaraziMDAliMSabbaghOBAbou-SamraAEbertJEaddyIDuJ.Paracentral acute middle maculopathy after sinus surgery: a case report and literature review. J Vitreoretin Dis. 2025;9(6):887-891.
SongWMarginesJBQaseemYAuASridharJ.Evaluation and management of uveitis in a patient with AIDS with low CD4 count and prior CMV retinitis. J Vitreoretin Dis. 2025;9(6):896-899.
27.
UeberrothJAOellersPREliottD.Electroretinographic Response Following Inadvertent Intravitreal Injection of Lidocaine 2%. J Vitreoretin Dis. 2025;9(6):900-903.
28.
AshbyNKaftanTOhlhausenMKimSMcGillEYehS.Resolution of vitreomacular traction following a commercial flight simulator experience. J Vitreoretin Dis. 2025;9(6):904-907.
